Catalyst Wire Dossier Catalyst Wire Dossier

proxalutamide

proxalutamide · Applied Biology, Inc.
Drug timelines are a Plus or Pro feature.

6 regulatory and trial events tracked for proxalutamide, covering 2021-06-23 to 2024-01-02. Get the full timeline:

Most recent: Clinical Trial Update: Proxalutamide (GT0918) Treatment for Outpatients With Mild or Moderate COVID-19 Illness [Phase 3]

See pricing